iGOGO -Assessment of CPR Skill,Willingness and Public AED in Layperson:A Cohort Study

December 12, 2022 updated by: Chang Gung Memorial Hospital
Out-of-hospital cardiac arrest (OHCA) is an important public health issue. Chang Gung Memorial Hospital, a university affiliated medical center in Taoyuan city, northern Taiwan, actively cooperated with government policy with 250 automated external defibrillators (AED) donation and implementation around many public places during period of 2012 to 2014. In addition, nearly 200 courses of first aid education and training of citizen were provided in the first and 52 courses in second program. According to the literature, a successful public AED implementation plans proceed with the following requirements: continuing education and training to improve and retain skills; maintaining a proper long-term operation of AED equipment;continued data collection of actual cases for analysis, quality control and feedback. In order to maintain the ability of emergency medical response among these 200 and more AED recipient areas, quality assurance with regular follow-up by medical directors, providing professional advice and feedback, repeat education and training should be proceed.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The aim of study is to continue the research development of the previous projects. First, in the previous research projects, investigators were found that the depth and rate of compression will fall behind the current standards by the American Heart Association after one year of training. The E-learning learning website has been completed, so the new project will launch parallel study and tracking of online (AIR) and field (BASE) stimulation teaching for a 2-year period. The participants would be stimulated at 6 and 18 months with short term on-line or base teaching program, and both groups received tests at 1 and 2 years. Second, NCOV-19 epidemic, many courses were cancelled and cannot be trained normally. Investigators will use feedback Annie to understand the operation status of remote students in online courses, and compare them with traditional field courses. (A1 VS B2) Third, the use of public AED for the first shock in OHCA patients were less than 10% in Taiwan. If the first shock could be saved the time, the prognosis of OHCA patients with shockable rhythm will be greatly improved. Therefore, implementing the early activation of the AED donated by our institute is much important. In the previous simulation test, it was found that the continuous education can activate the public AED 1 minute faster than the unit without training. Therefore, in the new plan, investigators Combined with the pre-hospital rescue data of the Taoyuan Fire Department, investigators will analyse the location of publicAED with the GIS and survival correlation. Fourth, investigators would apply the simulation teaching situation in the hospital to the pre-hospital: try to operate the simulation situation teaching plan of OHCA patients in various public places, so that the students can get the impression of the situation and maintain the skills.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Taiwan
      • Taoyuan, Taiwan, 333
        • Recruiting
        • Chang Gung Memorial Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

8 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Recipient of IGOGO AED donation project, other non-profit group and educational institutions, as well as personnel who participated in the initial and recurrent training in the Formosa Plastics Group including Nanya, Formosa Plastics and Chang Gung.

Description

Inclusion Criteria:

  1. agree to participate in the CPR course and sign the consent form to take part in the trial for further follow-up.
  2. satisfies the following age restrictions: a. Legal adult (>20 years old) or b. Underaged (12-20 years old) participants require consent form from the legal guardian.

Exclusion Criteria:

  1. Not willing to participate in the trial signed the consent form
  2. Inability to perform CPR in a kneeling position
  3. unwilling to be tracked
  4. Pregnant
  5. Hands unable to perform CPR

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
CONTROL
stimuli with traditional CPR education per half-year
Behavioral: CPR
HIGH QUALITY CPR
TREATMENT
stimuli with blended CPR education per half-year
Behavioral: CPR
HIGH QUALITY CPR

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Percentage of successful high-quality CPR
Time Frame: we intervention and evaluate the outcome per half-year
The students stimulate with the traditional education group or blended education per half-year. We evaluate the percentage of successful high-quality CPR between traditional and blended education groups.
we intervention and evaluate the outcome per half-year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Chang Gung Memorial Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Chip-Jin Ng, Dr., Chang Gung Memorial Hospital
  • Study Director: Cheng-Yu Chien, Dr., Chang Gung Memorial Hospital
  • Study Director: Li-Heng Tasi, Dr., Chang Gung Memorial Hospital
  • Principal Investigator: Ming-Fang Wang, Dr., Chang Gung Memorial Hospital
  • Principal Investigator: Wei-Chen Chen, Dr., Chang Gung Memorial Hospital
  • Principal Investigator: Yun-Ting Ku, Researcher, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2022

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 30, 2023

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 16, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 12, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 21, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 21, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 12, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202200559B0

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings